News

Gladstone in the News November 3, 2021

COVID’s Cardiac Connection

Scientific American—There is increasing evidence that some people who recover from COVID-19 suffer from lingering heart problems, a phenomenon known as post-COVID-19 cardiac syndrome. Senior Investigator Bruce Conklin explains that it’s important to investigate the long-term consequences of infection, and describes his team’s work showing that infecting heart cells with SARS-CoV-2 can result in dramatic structural damage.

Gladstone Experts COVID-19 Cardiovascular Disease Conklin Lab

Gladstone in the News October 12, 2021

New COVID-19 Pill Is Not a Substitute for the Vaccine, According to Experts—Here’s Why

ABC7 News—Gladstone President Deepak Srivastava, MD, and Senior Investigator Nevan Krogan, PhD, compare and contrast vaccines to Merck's new drug against COVID-19.

Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Krogan Lab Srivastava Lab

Gladstone in the News October 4, 2021

Cutting-Edge Medical Research/SF Public Defender Sues Courts/Pauli Murray Documentary

KALW—Gladstone President Deepak Srivastava, MD, is one of two Bay Area leaders in COVID-19 research discussing current progress in the development of novel treatment, prevention and detection methods, at Gladstone and in the Bay Area.

Gladstone Experts COVID-19 Cardiovascular Disease

Gladstone in the News July 6, 2021

Study Suggests Children Are Breathing CO2 When Wearing Masks, Experts Say Levels Are Not Dangerous

ABC7 News—A new study shows that wearing a mask increases slightly the amount of carbon dioxide children breathe. Gladstone President Deepak Srivastava, MD, cautions that the study was small, the increase in carbon dioxide is not known to be dangerous, and that wearing a mask and getting vaccinated remain the best protections against COVID-19.

COVID-19 Cardiovascular Disease Srivastava Lab

Article July 2, 2021

Gladstone Investigator Awarded Two Early-Career Grants

Funds will support Isha Jain’s innovative disease research with potential for big impact

Grants Cardiovascular Disease Jain Lab

Article June 23, 2021

Flipping a Molecular Switch for Heart Fibrosis

Gladstone researchers discover how to reverse cardiac scarring—and how this could treat heart failure

News Release Research (Publication) Heart Failure Cardiovascular Disease Alexanian Lab Srivastava Lab CRISPR/Gene Editing

Article June 21, 2021

How Do Developing Spinal Cords Choose “Heads” or “Tails”?

A new human organoid developed by Gladstone scientists mimics one of the key steps in early embryonic development

News Release Research (Publication) Cardiovascular Disease McDevitt Lab CRISPR/Gene Editing Stem Cells/iPSCs

Article May 12, 2021

Teaching a Computer Program to Track Cells

Gladstone researchers design a new artificial intelligence approach to simultaneously follow hundreds of cells in the lab as they divide, move, and interact

News Release Research (Publication) Cardiovascular Disease McDevitt Lab AI

Video April 9, 2021

Devoted to Heart Development

Watch presentations from the Bruneau Lab 20th Anniversary Symposium held on March 19, 2021, via Zoom

Cardiovascular Disease Bruneau Lab

Article March 15, 2021

New Insights into How COVID-19 Causes Heart Damage

Gladstone scientists discover how the novel coronavirus damages heart muscle cells, and create a system that can be used to screen potential therapies

News Release Research (Publication) COVID-19 Cardiovascular Disease Infectious Disease Conklin Lab McDevitt Lab Ott Lab

Gladstone in the News February 3, 2021

San Francisco Researchers Use Genetic Clues to Identify Possible Drug for Treating Heart Conditions

ABC7 News—Gladstone President Deepak Srivastava, MD, a pediatric cardiologist, explains how his group discovered a potential new drug to treat a debilitating disease due to the hardening of heart valves.

Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs

Article December 16, 2020

Isha Jain Joins Gladstone Institutes

A scientist since childhood, Jain will now lead a lab at Gladstone to study the balance of oxygen levels in the human body

Institutional News News Release Profile Cardiovascular Disease Jain Lab

Article December 14, 2020

Study Reveals Networks of Genes Involved in Congenital Heart Disease

The findings could point toward new ways to prevent or treat one of the most common birth defects

News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Bruneau Lab Human Genetics Stem Cells/iPSCs

Article December 10, 2020

A Potential Therapy for One of the Leading Causes of Heart Disease

A drug candidate found by Gladstone researchers could help prevent tens of thousands of heart surgeries every year

News Release Research (Publication) Heart Failure Cardiovascular Disease Srivastava Lab Theodoris Lab AI CRISPR/Gene Editing Disease Models Stem Cells/iPSCs

Gladstone in the News November 1, 2020

California Prop 14 May Change Lives of Sick Kids, Keep Taxpayer Funding of Stem Cell Therapy Research

USA Today—California Proposition 14 put funding for the Stem Cell Research Institute on the ballot this year. Gladstone President Deepak Srivastava, MD, explains how previous funding for stem cell research in California has helped bring the field to a point where stem cell–based therapies are now possible.

Gladstone Experts Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs